Cargando…

Mutation Analysis of the WT1 Gene in Myelodysplastic Syndromes

The WT1 tumor suppressor gene was examined for mutations in a panel of 44 patients with myelo‐dysplastic syndromes (MDS) including acute myelogenous leukemias (AML) secondary to MDS, using polymerase chain reaction single‐strand conformation polymorphism (PCR‐SSCP) analysis and sequencing analysis....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosoya, Noriko, Miyagawa, Kiyoshi, Mitani, Kinuko, Yazaki, Yoshio, Hirai, Hisamaru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1998
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5921914/ https://www.ncbi.nlm.nih.gov/pubmed/9765617 http://dx.doi.org/10.1111/j.1349-7006.1998.tb00634.x

Ejemplares similares

Frameshift Mutations of the hMSH6 Gene in Human Leukemia Cell Lines
por: Hosoya, Noriko, et al.
Publicado: (1998)

c‐Cbl Is Inducibly Tyrosine‐phosphorylated by Epidermal Growth Factor Stimulation in Fibroblasts, and Constitutively Tyrosine‐phosphorylated and Associated with v‐Src in v‐src‐transformed Fibroblasts
por: Odai, Hideharu, et al.
Publicado: (1995)

Tyrosine Phosphorylation of the Proto‐oncogene Product Vav and Its Association with the Adapter Grb2/Ash in a Human Leukemia Cell Line UT‐7
por: Hanazono, Yutaka, et al.
Publicado: (1995)

Mutations of N‐ras Oncogene in Myelodysplastic Syndromes and Lcukemias Detected by Polymerase Chain Reaction
por: Mano, Hiroyuki, et al.
Publicado: (1989)

Phase 1/2 study of the WT1 peptide cancer vaccine WT4869 in patients with myelodysplastic syndrome
por: Ueda, Yasunori, et al.
Publicado: (2017)

Implications of the germline variants of DNA damage response genes detected by cancer precision medicine for radiological risk communication and cancer therapy decisions
por: Hosoya, Noriko, et al.
Publicado: (2021)

Targeting DNA damage response in cancer therapy
por: Hosoya, Noriko, et al.
Publicado: (2014)

Synaptonemal complex proteins modulate the level of genome integrity in cancers
por: Hosoya, Noriko, et al.
Publicado: (2021)

Somatic role of SYCE2: an insulator that dissociates HP1α from H3K9me3 and potentiates DNA repair
por: Hosoya, Noriko, et al.
Publicado: (2018)

Genomic Organization of the Human WT1 Gene
por: Tadokoro, Keiko, et al.
Publicado: (1992)

Review of the Results of WT1 Peptide Vaccination Strategies for Myelodysplastic Syndromes and Acute Myeloid Leukemia from Nine Different Studies
por: Di Stasi, Antonio, et al.
Publicado: (2015)

WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Giudice, Valentina, et al.
Publicado: (2021)

A novel WT1 gene mutation in a chinese girl with denys‐drash syndrome
por: Wang, Faliang, et al.
Publicado: (2021)

WT1 Gene Mutations, rs16754 Variant, and WT1 Overexpression as Prognostic Factors in Acute Myeloid Leukemia Patients
por: Koczkodaj, Dorota, et al.
Publicado: (2022)

P790: THE EXPRESSION LEVEL OF WT1 MRNA IN PATIENTS WITH IDIOPATHIC CYTOPENIA OF UNDETERMINED SIGNIFICANCE (ICUS) PROGRESSING TO MYELODYSPLASTIC SYNDROME (MDS)
por: Ye, X., et al.
Publicado: (2022)

Prognostic impact of gene mutations in myelodysplastic syndromes with ring sideroblasts
por: Martín, Iván, et al.
Publicado: (2017)

Gonadal Function in 15 Patients Associated with WT1 Gene Mutations
por: Maesaka, Akiko, et al.
Publicado: (2006)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
por: Malcovati, Luca, et al.
Publicado: (2011)

CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q)
por: Bello, Erica, et al.
Publicado: (2015)

LncRNA Profiling Reveals That the Deregulation of H19, WT1-AS, TCL6, and LEF1-AS1 Is Associated with Higher-Risk Myelodysplastic Syndrome
por: Szikszai, Katarina, et al.
Publicado: (2020)

Anti‐tumor Effects of Interleukin‐4 and Interleukin‐5 against Mouse B Cell Lymphoma and Possible Mechanisms of Their Action
por: Wu, Hua‐Lang, et al.
Publicado: (1992)

Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation
por: Israyelyan, Anna, et al.
Publicado: (2014)

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
por: Rocquain, Julien, et al.
Publicado: (2010)

Mutation or loss of Wilms' tumor gene 1 (WT1) are not major reasons for immune escape in patients with AML receiving WT1 peptide vaccination
por: Busse, Antonia, et al.
Publicado: (2010)

Short telomere length and its correlation with gene mutations in myelodysplastic syndrome
por: Hwang, Sang Mee, et al.
Publicado: (2016)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
por: Wan, Ziqi, et al.
Publicado: (2020)

Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes
por: Gerstung, Moritz, et al.
Publicado: (2015)

High mutation burden in the checkpoint and micro-RNA processing genes in myelodysplastic syndrome
por: Moiseev, Ivan Sergeevich, et al.
Publicado: (2021)

Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia
por: Liu, Ming, et al.
Publicado: (2021)

Bioinformatics analysis of high frequency mutations in myelodysplastic syndrome-related patients
por: Wu, Kun, et al.
Publicado: (2021)

Correlation analysis between auto-immunological and mutational profiles in myelodysplastic syndromes
por: Cristiano, Antonio, et al.
Publicado: (2023)

Towards an understanding of kidney diseases associated with WT1 mutations
por: Dong, Lihua, et al.
Publicado: (2015)

Spliceosome mutations in myelodysplastic syndromes and chronic myelomonocytic leukemia
por: Chesnais, Virginie, et al.
Publicado: (2012)

Hemolytic uremic syndrome as the presenting manifestation of WT1 mutation and Denys-Drash syndrome: a case report
por: Alge, Joseph L., et al.
Publicado: (2017)

A high incidence of WT1 abnormality in bilateral Wilms tumours in Japan, and the penetrance rates in children with WT1 germline mutation
por: Kaneko, Y, et al.
Publicado: (2015)

Gene mutational analysis by NGS and its clinical significance in patients with myelodysplastic syndrome and acute myeloid leukemia
por: Yu, Jifeng, et al.
Publicado: (2020)

Prognostic significance of U2AF1 mutations in myelodysplastic syndromes: a meta-analysis
por: Li, Bixia, et al.
Publicado: (2019)

Bilateral Wilms’ tumors in an infant with Denys-Drash syndrome and rarely seen truncation mutation in the WT1 gene-exon 6
por: Modi, Jayesh, et al.
Publicado: (2015)

Myelodysplastic syndromes
por: Hellström Lindberg, Eva
Publicado: (2018)

Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome
por: Ochi, Tetsuro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6tf89amju37oof8hmcppbmqn6h